FINWIRES · TerminalLIVE
FINWIRES

研究快讯:CFRA维持对Vertex Pharmaceuticals Incorporated股票的买入评级

By

-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下: 在公布第一季度业绩后,我们将VRTX的目标股价从579美元下调至535美元,相当于2027年每股收益预期的24.4倍,低于VRTX过去10年的平均预期市盈率。我们维持对VRTX 2026年每股收益19.40美元的预期,以及对2027年每股收益21.92美元的预期。VRTX 2026年第一季度业绩表现强劲,营收增长显著,新产品成功上市,临床研发管线(尤其是肾脏领域)取得了重大进展。公司囊性纤维化(CF)产品线仍然是主要营收驱动力,而Casgevy和Gernavics等新产品也开始对增长做出显著贡献,约占第一季度产品总营收增长的25%。我们认为,产品线进展依然强劲,其中,povetacicept治疗IgA肾病的滚动生物制品许可申请(BLA)已完成,这标志着一个重要的监管里程碑。VRTX利用优先审评券,预计FDA将在六个月内完成审评,这令人鼓舞。

Related Articles

Asia

Catalyst Metals Completes Mining at Western Australia Open Pit; Shares Down 6%

Catalyst Metals (ASX:CYL) completed mining at the Trident open pit within the Plutonic Gold Belt in Western Australia, allowing for the establishment of a decline and the development of an underground mine, according to a Tuesday filing with the Australian bourse.Stockpiles generated from the open pit will be transported and blended through the Plutonic processing plant over the remainder of the year, the filing said.First ore from the underground mine is expected in 2027, per the filing.Shares fell 6% in morning trade on Tuesday.

$ASX:CYL
Asia

Ventia Services Group Secures Victorian Road Maintenance Contracts Across Grampians, Eastern Metropolitan Regions

Ventia Services Group (ASX:VNT, NZE:VNT) has been awarded new contracts by the Victorian Department of Transport and Planning to deliver road maintenance services across the Grampians and Eastern Metropolitan regions under the Victorian road maintenance contract model, according to a Tuesday filing with the Australian and New Zealand bourses.The contracts have an estimated combined value of about AU$340 million over a four-year base term, covering routine maintenance, planned maintenance programs, and minor capital works, subject to government budget approvals and road priorities, per the filing.The agreements also provide extension options of up to two additional years for Grampians and up to four additional years for Eastern Metropolitan, the filing said.The company will provide comprehensive road network services, including inspections, hazard and defect rectification, emergency response, and minor capital works across rural and metropolitan arterial roads, starting July 1, the filing added.The company's shares on the Australian and New Zealand exchanges rose by around 5% and 2%, respectively, in Tuesday's trade.

$ASX:VNT$NZE:VNT
Research

Research Alert: CFRA Maintains Hold Opinion On Shares Of Builders Firstsource, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target to $85 from $125, based on a 2027 P/E of 13.1x, a premium to the stock's 10-year average forward P/E of 12.1x, justified by cyclical trough market conditions. We lower our adjusted EPS estimates to $4.10 from $6.69 for 2026 and to $6.50 from $8.01 for 2027. BLDR posted Q1 2026 adjusted EPS of $0.27 vs. $1.51 (-82% Y/Y), well short of the $0.37 consensus. BLDR's Q1 sales fell 11% to $3.29B ($130M ahead of consensus), but gross margin contracted 220 bps to 28.3%. BLDR said it now expects 2026 net sales of $14.6B-$15.6B and adjusted EBITDA of $1.1B-$1.5B, versus prior expectations of $14.8B-$15.8B and $1.3B-$1.7B, respectively. Management said it remains focused on factors within its control, including serving customers, expanding its differentiated portfolio of value-added solutions, and leveraging technology to accelerate growth and drive operational excellence. We think BLDR's Q1 results underscore challenges the company faces from a weaker housing market.

$BLDR